Novel and promising approaches in COVID-19 treatment

被引：0

作者：

Asefy, Zahra ^{[1
]}

Rashidzadeh, Hamid ^{[2
]}

Mohammadi, Ali ^{[2
]}

Charehsaz, Mohammad ^{[3
]}

Sipahi, Hande ^{[3
]}

Aydin, Ahmet ^{[3
]}

Helvacioglu, Sinem ^{[3
]}

Khalilov, Rovshan ^{[4
,5
,6
]}

Zhdanov, Renad Ibragimovich ^{[5
]}

Danafar, Hossein ^{[6
]}

Hasanzadeh, Amir ^{[1
]}

Eftekhari, Aziz ^{[1
,5
]}

机构：

[1] Maragheh Univ Med Sci, Dept Pharmaceut Toxicol, Maragheh, Iran

[2] Zanjan Univ Med Sci, Zanjan Pharmaceut Biotechnol Res Ctr, Zanjan, Iran

[3] Yeditepe Univ, Fac Pharm, Dept Pharmaceut Toxicol, Istanbul, Turkey

[4] Baku State Univ, Dept Biophys & Biochem, Baku, Azerbaijan

[5] Moscow State Pedag Univ, Russian Inst Adv Study, 1-1 Malaya Pirogovskaya St, Moscow 119991, Russia

[6] Natl Acad Sci Azerbaijan, Inst Radiat Problems, Baku, Azerbaijan

来源：

JOURNAL OF RESEARCH IN PHARMACY | 2021年 / 25卷 / 06期

关键词：

Coronavirus; SARS-CoV-2; nano vaccine; ACE; 2; extracellular vesicles; RENIN-ANGIOTENSIN SYSTEM; MESENCHYMAL STEM-CELLS; INFLUENZA-VIRUS; EXTRACELLULAR VESICLES; CORONAVIRUS; INFECTION; RECEPTOR; ACE2;

D O I：

10.29228/jrp.68

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe respiratory infectious disease, known as coronavirus disease-19 (COVID-19). Over the past few months, a considerable rise in the incidence rate and prevalence of COVID-19 infection have been witnessed. Considering the high disease burden and rapid spread of the COVID-19 and no effective treatment is currently existing, stem cells, engineered nanobiomaterials, natural killer cells based therapy, RNA metabolites and extracellular vesicles are promising alternatives to tackle devastating epidemic. This review spotlights the applications and potential of above-mentioned methods in the treatment of COVID-19.

引用

页码：772 / 784

页数：13

共 48 条

[1] Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention
Ahmadian, Elham
Pennefather, Peter S.
Eftekhari, Aziz
Heidari, Reza
Eghbal, Mohammad Ali
[J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (11) : 1279 - 1288
[2] How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, Roy M.
Heesterbeek, Hans
Klinkenberg, Don
Hollingsworth, T. Deirdre
[J]. LANCET, 2020, 395 (10228) : 931 - 934
[3] Natural products' role against COVID-19
Antonio, Ananda da Silva
Moreira Wiedemann, Larissa Silveira
Veiga-Junior, Valdir Florencio
[J]. RSC ADVANCES, 2020, 10 (39) : 23379 - 23393
[4] Atluri S, 2020, PAIN PHYSICIAN, V23, pE71
[5] Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Barnes, Betsy J.
Adrover, Jose M.
Baxter-Stoltzfus, Amelia
Borczuk, Alain
Cools-Lartigue, Jonathan
Crawford, James M.
Dassler-Plenker, Juliane
Guerci, Philippe
Huynh, Caroline
Knight, Jason S.
Loda, Massimo
Looney, Mark R.
McAllister, Florencia
Rayes, Roni
Renaud, Stephane
Rousseau, Simon
Salvatore, Steven
Schwartz, Robert E.
Spicer, Jonathan D.
Yost, Christian C.
Weber, Andrew
Zuo, Yu
Egeblad, Mikala
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (06)
[6] Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Borba, Mayla Gabriela Silva
Val, Fernando Fonseca Almeida
Sampaio, Vanderson Souza
Alexandre, Marcia Almeida Araujo
Melo, Gisely Cardoso
Brito, Marcelo
Mourao, Maria Paula Gomes
Brito-Sousa, Jose Diego
Baia-da-Silva, Djane
Guerra, Marcus Vinitius Farias
Hajjar, Ludhmila Abrahao
Pinto, Rosemary Costa
Balieiro, Antonio Alcirley Silva
Pacheco, Antonio Guilherme Fonseca
Santos, James Dean Oliveira, Jr.
Naveca, Felipe Gomes
Xavier, Mariana Simao
Siqueira, Andre Machado
Schwarzbold, Alexandre
Croda, Julio
Nogueira, Mauricio Lacerda
Romero, Gustavo Adolfo Sierra
Bassat, Quique
Fontes, Cor Jesus
Albuquerque, Bernardino Claudio
Daniel-Ribeiro, Claudio-Tadeu
Monteiro, Wuelton Marcelo
Lacerda, Marcus Vinicius Guimaraes
[J]. JAMA NETWORK OPEN, 2020, 3 (04) : E208857
[7] RETRACTED: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (Retracted Article)
Cai, Qingxian
Yang, Minghui
Liu, Dongjing
Chen, Jun
Shu, Dan
Xia, Junxia
Liao, Xuejiao
Gu, Yuanbo
Cai, Qiue
Yang, Yang
Shen, Chenguang
Li, Xiaohe
Peng, Ling
Huang, Deliang
Zhang, Jing
Zhang, Shurong
Wang, Fuxiang
Liu, Jiaye
Chen, Li
Chen, Shuyan
Wang, Zhaoqin
Zhang, Zheng
Cao, Ruiyuan
Zhong, Wu
Liu, Yingxia
Liu, Lei
[J]. ENGINEERING, 2020, 6 (10) : 1192 - 1198
[8] Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients
Caracciolo, Massimo
Correale, Pierpaolo
Mangano, Carmelo
Foti, Giuseppe
Falcone, Carmela
Macheda, Sebastiano
Cuzzola, Maria
Conte, Marco
Falzea, Antonella Consuelo
Iuliano, Eleonora
Morabito, Antonella
Caraglia, Michele
Polimeni, Nicola
Ferrarelli, Anna
Labate, Demetrio
Tescione, Marco
Di Renzo, Laura
Chiricolo, Gaetano
Romano, Lorenzo
De Lorenzo, Antonino
[J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
[9] Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
Chen, Huijun
Guo, Juanjuan
Wang, Chen
Luo, Fan
Yu, Xuechen
Zhang, Wei
Li, Jiafu
Zhao, Dongchi
Xu, Dan
Gong, Qing
Liao, Jing
Yang, Huixia
Hou, Wei
Zhang, Yuanzhen
[J]. LANCET, 2020, 395 (10226) : 809 - 815
[10] Human influenza virus A/HongKong/156/97 (H5N1) infection
Claas, ECJ
de Jong, JC
van Beek, R
Rimmelzwaan, GF
Osterhaus, ADME
[J]. VACCINE, 1998, 16 (9-10) : 977 - 978

← 1 2 3 4 5 →